For each level, key provisions require evaluation and assessment at both the fund and portfolio.

Several months into the year, impacts can still be puzzling. Get succinct answers to complex questions.

The time is now for the life sciences industry to leverage benefits of tax reform R&D and Orphan Drug credits.

The Grant Thornton/Hart Energy survey reveals energy industry is approaching tax reform with caution.

Tax reform may make current business structures no longer tax efficient. Business planning is a must for manufacturers.

Aging infrastructure and funding shortfalls at top of priority list for both federal and state governments.

Is a lower corporate tax rate tempting you to make an entity change? Before converting, answer these questions.

With changes in both corporate and individual tax rates, the math has changed when it comes to entity choice.

Pass-throughs looking to take advantage of the new corporate rate cut need to consider the impact on the exit process.